Search

Cookies

We use cookies to improve your experience. By continuing, you accept our use of cookies.

Business

Daljeet Kohli: Mid- & Small-Cap Stocks Offer Alpha Beyond Crowded Large Caps

· · 2 min read

Market veteran Daljeet Kohli argues mid- and small-cap stocks provide greater alpha potential than large caps. He advocates for sector-specific baskets and bottom-up stock picking to identify underappreciated opportunities.

Market veteran Daljeet Kohli has recently outlined a compelling investment strategy, asserting that significant opportunities for outperformance, or "alpha," lie beyond India's frequently crowded large-cap universe. Ahead of launching his new portfolio management strategy, Kohli made it clear that mid- and small-cap stocks offer far greater potential for discerning investors.

The Case Against Large-Cap Dominance

Kohli argues that focusing solely on large-cap stocks provides little differentiation for portfolio managers. These prominent companies are already extensively tracked and efficiently priced by the market, leaving minimal room for an edge. He also highlighted the concentration risk inherent in headline indices, where sectors like banking, financials, and autos heavily dominate, leading to increasingly similar large-cap portfolios across different managers.

Why Mid- & Small-Cap Stocks Offer Broader Horizons

Moving beyond the top 100-150 companies, Kohli believes the investment landscape becomes far more expansive and dynamic. The broader market presents a vast spectrum of opportunities, encompassing established "old-economy" businesses, innovative new-age companies, and firms undergoing significant transitions. This extensive breadth is crucial for active management, enabling investors to identify niche leaders, emerging business models, and under-owned companies capable of delivering strong earnings surprises, even during periods of sluggish benchmark index performance.

Sector-Specific Baskets for Diversified Alpha

A distinctive element of Kohli's framework is his preference for constructing sector-specific baskets rather than simply chasing obvious market leaders. For instance, in the pharmaceutical sector, he suggests investors need not be confined to frontline giants like Sun Pharma. Instead, a well-structured portfolio could combine a Contract Development and Manufacturing Organization (CDMO) player, a domestic pharmaceutical company, an an international exporter, an Active Pharmaceutical Ingredient (API) manufacturer, and even a multinational drug firm. This approach effectively spreads risk while maintaining exposure to multiple earnings triggers within the same industry.

Bottom-Up Stock Picking: A Key Differentiator

In a volatile macroeconomic environment characterized by interest rate hikes, pressure on headline indices, and uneven sector performance, Kohli emphasizes that bottom-up stock selection is paramount. He contends that India remains a "stock-picker's market" due to the unusually high dispersion within sectors and indices. For investors seeking wealth creation, the focus should shift from merely holding benchmark heavyweights to identifying the right businesses within the broader market—precisely where Kohli believes flexibility, differentiation, and alpha potential still thrive.

Related